Johnson & Johnson financial data

Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
Location
One Johnson & Johnson Plz, New Brunswick, New Jersey
State of incorporation
New Jersey
Fiscal year end
December 29
Former names
JOHNSON & JOHNSON ET AL (to 1/23/1996)
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % -3.58%
Quick Ratio 24.1 % +7.78%
Debt-to-equity 144 %
Return On Equity 53.7 % +215%
Return On Assets 22.1 % +219%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.41B shares -7.39%
Entity Public Float 430B USD -8.9%
Common Stock, Value, Issued 3.12B USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.41B shares -7.57%
Weighted Average Number of Shares Outstanding, Diluted 2.43B shares -6.73%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 85.6B USD +5.68%
Research and Development Expense 483M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 20.1B USD +55.9%
Income Tax Expense (Benefit) 2.99B USD +102%
Net Income (Loss) Attributable to Parent 38.5B USD +202%
Earnings Per Share, Basic 15.3 USD/shares +216%
Earnings Per Share, Diluted 15.2 USD/shares +218%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.5B USD +32.9%
Marketable Securities, Current 745M USD -86.3%
Cash, Cash Equivalents, and Short-term Investments 26.2B USD -18.9%
Accounts Receivable, after Allowance for Credit Loss, Current 14.9B USD -8.59%
Inventory, Net 11.4B USD -11.1%
Assets, Current 57B USD -11.5%
Deferred Income Tax Assets, Net 10.3B USD +16.9%
Property, Plant and Equipment, Net 19.6B USD -2.69%
Operating Lease, Right-of-Use Asset 1B USD -9.09%
Intangible Assets, Net (Excluding Goodwill) 34.3B USD -27.7%
Goodwill 36.6B USD -19.7%
Other Assets, Noncurrent 14.1B USD +47.6%
Assets 172B USD -12.2%
Accounts Payable, Current 8.17B USD -17.5%
Employee-related Liabilities, Current 2.18B USD -2.38%
Accrued Liabilities, Current 10.3B USD -7.86%
Liabilities, Current 48.7B USD -19.3%
Accrued Income Taxes, Noncurrent 2.88B USD -32.9%
Deferred Income Tax Liabilities, Net 3.17B USD -28.2%
Other Liabilities, Noncurrent 15.1B USD +4.48%
Liabilities 102B USD -18.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.8B USD +14.7%
Retained Earnings (Accumulated Deficit) 153B USD +23.1%
Stockholders' Equity Attributable to Parent 70B USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 70B USD -1.2%
Liabilities and Equity 172B USD -12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.66B USD +12.3%
Net Cash Provided by (Used in) Financing Activities 546M USD -91.1%
Net Cash Provided by (Used in) Investing Activities -464M USD -114%
Common Stock, Shares Authorized 4.32B shares 0%
Common Stock, Shares, Issued 3.12B shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.61B USD -71.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.5B USD -5.18%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.77B USD +89.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 1.1B USD -15.4%
Payments to Acquire Property, Plant, and Equipment 807M USD -6.49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.01B USD +1737%
Property, Plant and Equipment, Gross 47.6B USD -5.52%
Deferred Income Tax Expense (Benefit) -1.56B USD -1.23%
Deferred Federal Income Tax Expense (Benefit) -3.44B USD -72.9%
Current Income Tax Expense (Benefit) 5.8B USD +26.8%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 2.5B USD +47.1%
Operating Lease, Payments 200M USD 0%
Current Federal Tax Expense (Benefit) 2.71B USD +19%
Amortization of Intangible Assets 4.5B USD +15.4%
Depreciation, Depletion and Amortization 1.82B USD -3.46%
Deferred Tax Assets, Net of Valuation Allowance 12.7B USD -1.29%
Share-based Payment Arrangement, Expense 1.09B USD +5.74%
Interest Expense 715M USD +49.6%